UBS O'Connor’s Corazon Capital V838 Monoceros Corp Warrant CRZNW Stock Holding History

UBS O'Connor’s Portfolio CRZNW Stock Details CRZNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-79,540	Closed	-$2K	–	798
2022 Q4	$2K	Hold	79,540	–	–	﹤0.01%	742
2022 Q3	$3K	Sell	79,540 -7,963	-9%	-$713	﹤0.01%	951
2022 Q2	$13K	Hold	87,503	–	–	﹤0.01%	936
2022 Q1	$31K	Buy	87,503 +1,542	+2%	+$780	﹤0.01%	925
2021 Q4	$57K	Buy	85,961 +2,302	+3%	+$1.72K	﹤0.01%	898
2021 Q3	$59K	Hold	83,659	–	–	﹤0.01%	874
2021 Q2	$86K	Buy	+83,659	New	+$73K	﹤0.01%	837

UBS O'Connor's CRZNW Position: Q1 2023 in Review

UBS O'Connor sold out of Corazon Capital V838 Monoceros Corp Warrant (CRZNW) in Q1 2023, closing a stake of 79,540 shares — an estimated $2K sold.

UBS O'Connor first reported a position in CRZNW in Q2 2021 and held it in 7 quarters. The position peaked at $86K in Q2 2021. 0 funds tracked by Wall St. Rank hold CRZNW as of Q1 2023.

UBS O'Connor reported no remaining Corazon Capital V838 Monoceros Corp Warrant position as of Q1 2023 after selling out during the quarter.
UBS O'Connor sold 79,540 Corazon Capital V838 Monoceros Corp Warrant shares in Q1 2023, an estimated $2K.
UBS O'Connor first reported a position in Corazon Capital V838 Monoceros Corp Warrant in Q2 2021 and held it in 7 quarters.
UBS O'Connor's Corazon Capital V838 Monoceros Corp Warrant position peaked at $86K in Q2 2021.
0 funds tracked by Wall St. Rank held Corazon Capital V838 Monoceros Corp Warrant as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.